Correlation Between Acumen Pharmaceuticals and Connect Biopharma
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Connect Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Connect Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Connect Biopharma Holdings, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Connect Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Connect Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Connect Biopharma.
Diversification Opportunities for Acumen Pharmaceuticals and Connect Biopharma
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Acumen and Connect is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Connect Biopharma Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Connect Biopharma and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Connect Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Connect Biopharma has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Connect Biopharma go up and down completely randomly.
Pair Corralation between Acumen Pharmaceuticals and Connect Biopharma
Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to under-perform the Connect Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Acumen Pharmaceuticals is 1.16 times less risky than Connect Biopharma. The stock trades about -0.16 of its potential returns per unit of risk. The Connect Biopharma Holdings is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 119.00 in Connect Biopharma Holdings on October 25, 2024 and sell it today you would lose (17.00) from holding Connect Biopharma Holdings or give up 14.29% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acumen Pharmaceuticals vs. Connect Biopharma Holdings
Performance |
| Timeline |
| Acumen Pharmaceuticals |
| Connect Biopharma |
Acumen Pharmaceuticals and Connect Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acumen Pharmaceuticals and Connect Biopharma
The main advantage of trading using opposite Acumen Pharmaceuticals and Connect Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Connect Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Connect Biopharma will offset losses from the drop in Connect Biopharma's long position.| Acumen Pharmaceuticals vs. Terns Pharmaceuticals | Acumen Pharmaceuticals vs. X4 Pharmaceuticals | Acumen Pharmaceuticals vs. Day One Biopharmaceuticals | Acumen Pharmaceuticals vs. Hookipa Pharma |
| Connect Biopharma vs. Assembly Biosciences | Connect Biopharma vs. Instil Bio | Connect Biopharma vs. CytomX Therapeutics | Connect Biopharma vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |